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Qualitative Research and Trials
The contribution qualitative research can make to improving intervention and trial design, 
evaluation and implementation is well recognised (O’Cathain et al, 2013). 
Qualitative methods are often used alongside quantitative methods within a process evaluation to 
explore trial processes, intervention components and mechanisms in relation to context. Many different 
qualitative methodologies are used. Here we consider the application of one qualitative methodology, 
case study design, as it is being used within the OPAL trial.
The OPAL Trial   
The OPAL trial tests a complex intervention for women with urinary incontinence (UI) 
(OPAL ISRCTN 57746448). 
The aim is to determine the effectiveness and cost-effectiveness of basic pelvic floor muscle training 
(PFMT) compared to biofeedback-mediated intensive PFMT for the treatment of stress or mixed (stress 
and urgency) female UI. Women with stress or mixed UI (n=600) were randomised to either basic 
PFMT or biofeedback intensified PFMT (Fig. 1). The primary outcome is severity of UI at 24 months 
(measured using the ICIQ-UI score).  
The area in orange in Fig. 1 is the process evaluation which aims to identify and investigate the possible 
mediating factors that impact upon the effectiveness of the intervention (including intervention 
fidelity), how these mediating factors influence effectiveness, and whether the factors differ between 
randomised groups.
The area shaded in grey in  Fig. 1 is the two-tailed qualitative case study which aims to:  investigate 
women’s experiences of intervention in both trial arms, identify the barriers and facilitators which 
impact short- and long-term adherence, explain the process through which they influence adherence, 
and identify whether these differ between randomised groups.
The process evaluation and case study are integral to the research with a view to adding value to the 
trial (O’Cathain et al, 2014). Specifically, both the longitudinal qualitative case study and mixed methods 
process evaluation have been developed in order to explain trial outcomes as well as providing analysis 
that will support a better understanding of trial research and the intervention processes.
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Case Study Design
Case study methodology is advocated for exploring real life phenomena within a 
contemporary context (Yin 2014). 
Case study design lends itself to investigations that aim to understand, in detail, how or why events 
occur. Hence the design is well suited to a study that aims to understand: 1) what factors influence 
short and longer term adherence; 2) how they influence adherence; and 3) what impact this has on 
outcome. Our study is also longitudinal, thus fitting well with a trial that aims to improve the primary 
outcome at two years through long term adherence.  
Case studies come in many forms, such as individual or multiple case studies. There are varying 
approaches advocated by different researchers (Stake 1995, Thomas 2016, Yin 2015). Our design is 
heavily influenced by Yin. We are using a two-tailed case study design, which means multiple cases 
from each trial arm (n=20 cases in each arm) are sampled with a view to enabling comparison between 
the trial arms (Fig. 2) Mirroring the trial data collection, our case study is longitudinal with women 
interviewed four times (baseline, post-treatment, 12 months, and 24 months post-randomisation). 
Thus, the case is built and summarised over two years with four data points for each woman.
Analysis starts with a case summary for each case.  Each case is then systematically compared to other 
cases within the tail (trial arm). Finally the tails (trial arms) are compared using some predefined and 
some iteratively developed theoretical propositions (hypotheses). The nature of the analysis encourages 
a move beyond description to explanation; for example, understanding why a specific contextual 
factor has a specific influence in a specific way on the primary outcome.
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Why is case study methodology useful for 
qualitative studies of complex intervention trials
• We know how important understanding context is to knowledge about how an intervention works 
(Wells et al, 2011). The depth of data generated from a methodological design that targets detailed 
understanding will allow explanations of how and why the intervention works or does not.
• A trial tests the effectiveness of an intervention in comparison to a control. Case study design can 
help uncover differences in the detail between intervention and control cases in a way that supports 
comparison and, importantly, explanation. Case study design addresses ‘why’ an intervention works 
(or does not) and the main trial investigates ‘if’ an intervention works or not.
• O’Cathain et al (2013) argue that qualitative studies associated to trials have several foci. Three of 
these are important for OPAL: the intervention being trialled; the trial processes and the outcomes. 
The case study design supports all of these purposes, for example, by helping to understand how 
the intervention is understood to be delivered in detail from the perspectives of the women who 
receive it and what impact women perceive the delivery has on their UI outcome over time.
• Trials often measure outcomes long after the intervention is delivered. This longitudinal element 
often means that the extrinsic contextual factors that may influence the outcome may continue to 
have influence or there may be new influences on the outcome that are important to understand. 
For OPAL our primary outcome is at two years, 18 months after the intervention delivery ends. 
Understanding how other factors may or may not influence the outcome is important, as is how 
this differs (or doesn’t) between the randomised groups. The complex interplay of how these 
factors affect an individual case (woman) is central to understanding how the intervention works 
or does not work.
Lessons about case study research linked to trials 
for the opal trial (… so far)
• A longitudinal study is time consuming, the volume of data is large and it needs appropriate 
resource to gather and analyse the data.  We are fortunate our funders have resourced this well.
• Attrition over time is higher than anticipated. While this mirrors the main trial it is higher for a 
qualitative study than we expected. The impact on the analysis is as yet unknown.
• In OPAL, the case study and process evaluation are linked but distinct. We have worked in ways 
that promote the links between the two. However, it is not always straight forward and remains a 
work in progress. We aim to triangulate the case study and evaluation analysis to further enhance 
our understanding of adherence in the longer term.
Figure 1: The OPAL Trial Flow Diagram.
Figure 2: The two tailed case study design.
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Trial
Women newly referred with stress or  
mixed urinary incontinence approached  
at 14 centres
Women assessed for presence of stress or 
mixed UI and other inclusion/exclusion criteria
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assessment of pelvic floor muscles
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an estimated 860 eligible women
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